Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nastim appears to refer most plausibly to Natstim, a Bulgaria-based healthcare company focused on the development, manufacture, and consulting of scientifically formulated dietary supplements. The company emphasizes products based on patented immunostimulators produced biotechnologically by Bul Bio at the National Center of Infectious and Parasitic Diseases, and it also develops private-label and distributor products. Its team reportedly participated in the creation and production of well-known immunostimulatory medicines such as Respivax and Urostim. Nastim/Natstim operates a small certified manufacturing base and serves a range of health categories including immune, urinary, digestive, cardiovascular, pediatric, and supportive oncology products. The available evidence suggests it is a commercial-stage nutraceutical and healthcare manufacturer rather than a clinical-stage biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nastim.